Abstract:Background and purpose:Pancreatic carcinoma is a kind of malignant disease with the rising tendency of incidence and poor prognosis.Little progress has been made on the treatment of advanced pancreatic carcinoma during the past 2 decades.The combined mordality for the unresectable pancreatic carcinoma is controversial.We retrospectively reviewed the clinical data and the results of transarterial intervention alone or transarterial intervention combined with radiotherapy,analyzed the prognostic factors for patients with unresectable pancreatic carcinoma.Methods:We retrospective analyzed 105 patients with locally advanced and metastatic pancreatic carcinoma.Univariate and multivariate statistical methods were used to determine significant prognostic factors and therapy program for overall survival(OS).Results:For all patients,the median survival time(MST) was 9.0 months,1-year and 2-year OS were 31.2% and 12.2% respectively.For the locally advanced vs phase Ⅳ patients,the MST,1-year,2-year OS were 9.1 vs 7.6 months,33.2% vs 29.3% and 14.7% vs 9.1% respectively.On univariate analysis,the number of interventional therapy,whether combined with radiotherapy or not,the choice of gemcitabine programs and primary tumor site were important factors for OS.For all 105 patients,the MST of patients who received multiple transarterial therapy was 4.9 months longer than those who had single therapy(12.5 vs 7.6 monthes,P=0.010).1-year and 2-year OS were 51.5% vs 22.2% and 20.7% vs 8.1%.The MST of patients who received combined therapy was 4.3 months longer compared with who had only interventional therapy(11.9 vs 7.6 monthes,P=0.003),1-year,2-year OS were 48.5% vs 21.8% and 27.7% vs 2.7%.The MST of patients who received gemcitabine programs was 2.2 months longer compared with who had other programs(9.8 vs 7.6 monthes,P=0.018),1-year,2-year OS were 37.5% vs 18.8% and 20.3% vs 3.1%.The MST of patients with pancreatic head cancer was 3.0 months longer compared with the patients whose cancer located in pancreatic body or tail(10.5 vs 7.5 monthes,P=0.031),1-year,2-year OS were 40.2% vs 22.0% and 6.3% vs 8.8%.On multivariate analysis,Interventional therapy combined radiotherapy was independent prognostic factor for OS,it could decrease death risk for all patients 46%(95%CI: 0.272-0.891,P=0.047).Conclusion:In the current study,transarterial intervention combined with radiotherapy can improve overall survival among patients with unresectable pancreatic cancer.

Observation of hypofractionated three dimensional conformal intensity modulated radiation therapy for lo-cally advanced pancreatic carcinoma

Three-dimensional Conformal Radiotherapy Combined with FOLFOX4 Chemotherapy for Unresectable Recurrent Rectal Cancer

Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer: Results of Feasibility Study

Outcome of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy for inoperable locally advanced pancreatic cancer

Three Dimensional-Conformal Radiotherapy Combined with Gemcitabine Chemotherapy for Locally Advanced Pancreatic Cancers

Clinical observation of high intensity focused ultrasound plus S-1 for advanced pancreatic carcinoma

Induction Chemotherapy with Gemcitabine, Oxaliplatin, and 5-Fluorouracil/leucovorin Followed by Concomitant Chemoradiotherapy in Patients with Locally Advanced Pancreatic Cancer: a Taiwan Cooperative Oncology Group Phase II Study.

Results of Treatment of Patients with Advanced Pancreatic Carcinoma Treated by Intra-arterial Chemotherapy Combined with 3-D Conformal Radiotherapy

The Efficacy Of A New High-Intensity Focused Ultrasound Therapy For Metastatic Pancreatic Cancer

A retrospective analysis of patients with unresectable pancreatic cancer treated with combined transarterial intervention and three dimensional conformal radiotherapy

Analysis of the Efficacy of Transcatheter Arterial Infusion Chemotherapy in the Treatment of Pancreatic Carcinoma

Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy

Clinical Study on the Effect of Hypofractionated Three -Dimensional Conformal Radiation Therapy in the Treatment of Non -Small Cell Lung Cancer

Effect of Three-Dimensional Conformal Radiotherapy Versus Dose Boosted with Gamma Ray ;stereotactic Body Radiotherapy on Locally Advanced Pancreatic Cancer

Real-world Response of Patients with Locally Advanced Pancreatic Adenocarcinoma to High Intensity Focused Ultrasound Treatment: a Single-Center, Observational Study in China

Concomitant Chemotherapy with Radiotherapy in Locally Advanced Pancreatic Cancer

Exploration of Superior Modality: Safety and Efficacy of Hypofractioned Image-Guided Intensity Modulated Radiation Therapy in Patients with Unresectable but Confined Intrahepatic Hepatocellular Carcinoma

HIGH INTENSITY FOCUSED ILTRASOUND IN COMBINATION WITH OCTREOTIDE TREATED PATIENTS WITH ADVANCED PANCREATIC CARCINOMA: ARANDOMIZED CONTROLLED CLINICAL RESEARCH

Clinical Efficacy of CyberKnife Radiotherapy for Locally Advanced Pancreatic Carcinoma

Dosimetric feasibility on hypofractionated intensity-modulated radiotherapy and simultaneous integrated boost for locally advanced unresectable pancreatic cancer with helical tomotherapy

The multidisciplinary treatment of locally advanced pancreatic cancer